Affinity Whole Health, a pioneer in personalized healthcare solutions with a focus on in-home weight loss and hormone therapies, announces the introduction of its new compounded GLP-1pre-filled syringes, a unique and patient-centric offering in the weight loss and metabolic health space.The pre-filled syringes offer unparalleled convenience for at-home administration, as patients can now avoid the hassle of drawing medication from vials or making weekly office visits for injections.
In line with this advancement, Affinity Whole Health is offering compounded semaglutide for $349 per month and compounded tirzepatide for $449 per month at any dose. This fixed pricing model is a game-changer for patients requiring higher doses, who often face escalating costs with other providers.
Affinity Whole Health’s pricing model is straightforward and transparent. The monthly fee covers all aspects of the treatment, with no extra or hidden fees. This approach aligns with the company’s mission to provide clear, honest, and patient-centric care.
“We believe effective healthcare should be accessible and affordable,” says Dr. Michael Koehler, Medical Director at Affinity Whole Health. “Our fixed pricing model for GLP-1 medications, regardless of dosage, reflects our commitment to reducing financial barriers to optimal health outcomes.”
In line with Affinity Whole Health’s commitment to accessible care, these enhanced offerings do not require insurance. This opens doors for patients who may not have coverage for weight loss treatments or those who prefer to manage their healthcare costs directly.
Matt Jones, CEO of Affinity Whole Health, emphasizes the impact of this new offering: “Our new compounded GLP-1 pre-filled syringes represent a significant step forward in making effective weight loss treatments more accessible and affordable. We’re not just offering a product; we’re providing a pathway to better health that’s both convenient and cost-effective.”
This innovative approach to GLP-1 medications further cements Affinity Whole Health’s position as a pioneer in personalized healthcare solutions. By combining cutting-edge treatments with patient-friendly pricing and delivery methods, Affinity Whole Health continues to transform the landscape of weight loss and metabolic health management.
For more information about the new compounded GLP-1 pre-filled syringes or to schedule a consultation, visit Affinity Whole Health’s website.
About Affinity Whole Health
Affinity Whole Health is a leading provider of personalized healthcare solutions, specializing in in-home weight loss and hormone therapies. With a patient-centric approach and a commitment to innovation, Affinity Whole Health offers cutting-edge treatments and comprehensive wellness programs tailored to each individual’s unique needs. Serving patients across the Midwest with offices in Cleveland, Columbus, Indianapolis, and Chicago, Affinity Whole Health is dedicated to empowering people to live better, healthier lives through personalized care and long-term health partnerships. To learn more about Affinity Whole Health, visit affinitywholehealth.com.